- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Partnering opportunities
- A complete cure for HBV
- A stable efficacious Toxoplasma vaccine
- Activating SMCHD1 to treat FSHD
- Improving vision outcomes in retinal detachment
- Intercepting inflammation with RIPK2 inhibitors
- Novel inhibitors for the treatment of lupus
- Novel malaria vaccine
- Precision epigenetics silencing SMCHD1 to treat Prader Willi Syndrome
- Rethinking CD52 a therapy for autoimmune disease
- Targeting minor class splicing
- Royalties distribution
- Start-up companies
- Partnering opportunities
- Collaborators
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- People
- Anne-Laure Puaux
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Alyssa Barry
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Daniel Gray
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Emma Josefsson
- Associate Professor Ethan Goddard-Borger
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Murphy
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeanne Tie
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Leanne Robinson
- Associate Professor Marco Herold Marco Herold
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Matthew Ritchie
- Associate Professor Melissa Davis
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Peter Czabotar
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Sandra Nicholson
- Associate Professor Sant-Rayn Pasricha
- Associate Professor Seth Masters
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Wai-Hong Tham
- Associate Professor Wei Shi
- Catherine Parker
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gemma Kelly
- Dr Gwo Yaw Ho
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Joanna Groom
- Dr John Wentworth
- Dr Kelly Rogers
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Melissa Call
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Samir Taoudi
- Dr Shalin Naik
- Dr Sheau Wen Lok
- Dr Simon Chatfield
- Dr Tracy Putoczki
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Joel Chibert
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Lew
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Gabrielle Belz
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor Jane Visvader
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marc Pellegrini
- Professor Marnie Blewitt
- Professor Melanie Bahlo
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Burgess
- Professor Tony Papenfuss
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Undergraduate
- Student research projects
- A new regulator of stemness to create dendritic cell factories for immunotherapy
- Advanced methods for genomic rearrangement detection
- Control of cytokine signaling by SOCS1
- Defining the protein modifications associated with respiratory disease
- Delineating the pathways driving cancer development and therapy resistance
- Developing a new drug that targets plasmacytoid dendritic cells for the treatment of lupus
- Development and mechanism of action of novel antimalarials
- Development of a novel particle-based malaria vaccine
- Development of tau-specific therapeutic and diagnostic antibodies
- Discovering novel therapies for major human pathogens
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Epigenetic biomarkers of tuberculosis infection
- Essential role of glycobiology in malaria parasites
- Evolution of haematopoiesis in vertebrates
- Human lung protective immunity to tuberculosis
- Identifying novel treatment options for ovarian carcinosarcoma
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigating the role of mutant p53 in cancer
- Microbiome strain-level analysis using long read sequencing
- Minimising rheumatic adverse events of checkpoint inhibitor cancer therapy
- Modelling spatial and demographic heterogeneity of malaria transmission risk
- Naturally acquired immune response to malaria parasites
- Predicting the effect of non-coding structural variants in cancer
- Structural basis of catenin-independent Wnt signalling
- Structure and biology of proteins essential for Toxoplasma parasite invasion
- T lymphocytes: how memories are made
- TICKER: A cell history recorder for longitudinal patient monitoring
- Targeting host pathways to develop new broad-spectrum antiviral drugs
- Targeting post-translational modifications to disrupting the function of secreted proteins
- Targeting the epigenome to rewire pro-allergic T cells
- Targeting the immune microenvironment to treat KRAS-mutant adenocarcinoma
- The E3 ubiquitin ligase Parkin and mitophagy in Parkinson’s disease
- The molecular controls on dendritic cell development
- Understanding malaria infection dynamics
- Understanding the genetics of neutrophil maturation
- Understanding the neuroimmune regulation of innate immunity
- Understanding the proteins that regulate programmed cell death at the molecular level
- Using cutting-edge single cell tools to understand the origins of cancer
- When healthy cells turn bad: how immune responses can transition to lymphoma
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Lilly Backshell
- Megan Kent
- Naomi Jones
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Wayne Cawthorne
- Wil Lehmann
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- WEHI.TV
Jason Tye-DIn-Projects
Researcher:
Projects
If you are interested in participating in or learning more about our studies, please email coeliac@wehi.edu.au or call +61 3 9345 2300 and leave a message.
Super Content:
We have discovered how oats incite a harmful immune response in 8 per cent of people with coeliac disease
How does gluten make people with coeliac disease and gluten sensitivity sick?
Our studies in adults and children with coeliac disease have provided detailed knowledge of the key parts of gluten harmful to people with coeliac disease. However, how gluten triggers adverse symptoms such as vomiting, pain or diarrhoea in people with coeliac disease remains poorly understood.
This study will examine immune responses in the blood stream and small intestine after people with coeliac disease, gluten sensitivity and healthy volunteers consume a small meal containing gluten. Testing will involve a detailed study of the immune cells and employ a variety of advanced approaches including examining which genes are turned on. The results will provide a unique insight into how symptoms occur to gluten and potentially define targets suitable for treatment to better manage symptoms. The study will also validate the role of cytokine measurement as a diagnostic test in coeliac disease and biomarker linked to symptoms.
Are oats toxic in coeliac disease?
The safety of oats for people with coeliac disease is controversial. Australia and New Zealand exclude oats from the gluten-free diet due to safety concerns, but many other countries do not. Oat is a nutritious grain that is high in fibre and may have a range of health benefits, but it is important to determine if they can be safely consumed by people with coeliac disease.
We have shown that almost 10 per cent of people with coeliac disease have T cells that are triggered by oats to promote an inflammatory response, potentially putting them at risk of harm. This study aims to definitively determine if oats are safe to consume in coeliac disease, if safety can be determined by an immune blood test or food test, and whether a specific type or dose of oats is necessary for safe consumption.
This study will involve the consumption of contamination-free oats or oat protein, immune blood tests and for some, gastroscopy and biopsy of the small bowel.
Establishing the clinical benefit of a genomic tool for people with coeliac disease
The information in a person’s whole genetic code (genome) has enormous potential for being used to improve that individual’s medical care and treatment. A genomic test for people with coeliac disease is particularly appealing as this illness has a strong genetic component.
In collaboration with Professor Mike Inouye, Dr Gad Abraham and team (Baker Institute) we are validating a genomic risk tool that can help identify people at higher risk of developing coeliac disease more accurately than the current HLA-DQ2/8 gene test.
This study will examine the usefulness of this tool in a large number of people who have coeliac disease, are related to someone with coeliac disease or are non-coeliac controls. The tool may help identify which person, for example a relative, is at high-risk for coeliac disease development and needs closer monitoring. Genomic information may also provide insights into how coeliac disease may behave over time, such as those at higher risk of developing specific complications.
We aim to use this information to guide and improve medical care.
Why does the gluten free diet fail?
The gluten-free diet is the main treatment for coeliac disease, yet many patients continue to have intestinal damage or experience symptoms despite many years on the diet. Ongoing intestinal damage is concerning as it is associated with a higher rate of complications such as osteoporosis, infections, refractory coeliac disease and cancers such as lymphoma.
This project is investigating the reasons why the gluten-free diet fails in some patients despite their best attempts to exclude gluten. While it is assumed that low amounts of inadvertent gluten exposure is responsible for dietary failure, the actual causes for this have not been systematically addressed. This study is exploring the role of gluten contamination in commercial gluten-free foods and gluten-free products sold in food outlets, examining food handling, labelling and testing practices in industry, and looking at patient factors that contribute to knowledge and compliance to the diet.
The findings will inform targeted strategies to improve gluten-free diet outcomes for people with coeliac disease.
What is the role of the microbiome in coeliac disease?
While specific genes, such as HLA-DQ2 and/or HLA-DQ8, are critical for the development of coeliac disease, environmental factors are also considered important, possibly as ‘triggers’ of disease. How they might do this is a very important question.
Emerging evidence suggests an important role for the eco-system of microbial organisms in the gastrointestinal tract, termed the ‘microbiome’. For example, studies undertaken with collaborators Professor Elena Verdu (McMaster University, Canada) and Professor Jamie Rossjohn (Monash University) have implicated Pseudomonas bacteria in coeliac disease via a number of different mechanisms. The research raises the possibility that specific alterations in the microbiome may have an important effect on gluten immunity and could affect the risk for coeliac disease development in genetically susceptible people.
Assessing spleen function and infection risk
The spleen plays a crucial role in antibody generation and defense from infections.
In people with coeliac disease, spleen function can be impaired (‘hyposplenism’), but the size of this issue is unclear and there is no Australian information. Hyposplenism is associated with higher rates of infections, including serious ones such as pneumococcal pneumonia.
This study is assessing spleen function in people with newly diagnosed and treated coeliac disease to determine how hyposplenism affects immune function, the risk of infections and adequacy of vaccination responses.
Assessing non-invasive tools that measure accidental gluten intake
Establishing how well a person is following a gluten free diet is difficult. Current tools rely on assessing a person’s diet or using antibody tests or intestinal biopsy, but these only indirectly reflect gluten exposure and they are not very helpful at determining if gluten is still being consumed.
This study is assessing a new technology designed to objectively measure the presence of gluten (specifically, fragments of gluten called peptides) in a person’s stool (faeces) or urine. This test, called a gluten immunogenic peptide (GIP) assay, is highly sensitive for detecting tiny amounts of gluten ingested by a person. They offer the potential to help doctors determine when a person with coeliac disease who is following a gluten free diet is actually consuming gluten. This randomised, double-blind study aims to determine the best way to use these tests to detect gluten exposure which can provide valuable information for the patient and treating doctor.